Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
25/07/202415:33Business WireRed River's Curtis Puckett Appointed to NCMA Board of Advisors
25/07/202415:33Business WireAir Lease Corporation Announces the Delivery of One Airbus A321-200neo Aircraft to Centrum Air (Uzbekistan)NYSE:ALAir Lease Corporation
25/07/202415:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:LTCNGrayscale Litecoin Trust LTC (QX)
25/07/202415:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBTYKLiberty Global Ltd
25/07/202415:32Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NTCTNetscout Systems Inc
25/07/202415:32Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:NOVVUNova Vision Acquisition Corporation
25/07/202415:32Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EMLDUFTAC Emerald Acquisition Corporation
25/07/202415:32Business WireMaterion Corporation to Announce Second Quarter Financial Results on August 5NYSE:MTRNMaterion Corporation
25/07/202415:31Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
25/07/202415:31Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:GS-JGoldman Sachs Group Inc
25/07/202415:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:SAMBoston Beer Company Inc
25/07/202415:31Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NTCTNetscout Systems Inc
25/07/202415:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TECHBio Techne Corporation
25/07/202415:30Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NYSE:NVSNovartis AG
25/07/202415:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SILOSilo Pharma Inc
25/07/202415:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AKANAkanda Corporation
25/07/202415:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:AULT-DAult Alliance Inc
25/07/202415:30GlobeNewswire Inc.USCB Financial Holdings, Inc. Reports Record Fully Diluted EPS Since Going Public of $0.31 for Q2 2024NASDAQ:USCBUSCB Financial Holdings Inc
25/07/202415:30GlobeNewswire Inc.Ellomay Capital Announces Results of 2024 Annual General Meeting of ShareholdersELLO
25/07/202415:30Business Wiree.l.f. Beauty Announces Earnings Release Date for First Quarter Fiscal 2025 ResultsNYSE:ELFe l f Beauty Inc
25/07/202415:30GlobeNewswire Inc.Zymeworks Appoints Leone Patterson as Chief Business and Financial OfficerNASDAQ:ZYMEZymeworks Inc
25/07/202415:30Business WireChimera Investment Corporation Announces Date of Second Quarter 2024 Financial Results and Conference CallNYSE:CIMChimera Investment Corporation New
25/07/202415:30GlobeNewswire Inc.Travere Therapeutics to Report Second Quarter 2024 Financial ResultsNASDAQ:TVTXTravere Therapeutics Inc
25/07/202415:30GlobeNewswire Inc.Red River Bancshares, Inc. Announces Quarterly Cash DividendNASDAQ:RRBIRed River Bancshares Inc
25/07/202415:30Business WireCF Industries Announces Emissions Reduction Project at Yazoo City, MS, Facility, Agreement with ExxonMobil to Transport and Sequester Up to 500,000 Metric Tons CO2 AnnuallyNYSE:CFCF Industries Holdings Inc
25/07/202415:30Business WireOPAL Fuels Announces Second Quarter 2024 Earnings Release Date and Conference CallNASDAQ:OPALOPAL Fuels Inc
25/07/202415:30Business WireFirst Business Bank Reports Second Quarter 2024 Net Income of $10.2 MillionNASDAQ:FBIZFirst Business Financial Services Inc
25/07/202415:30GlobeNewswire Inc.FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis’ UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) TreatmentEU:ALCLSCellectis Nom Eo 05
25/07/202415:30GlobeNewswire Inc.Comstock Inc. to Host Q2 Earnings Call on August 8, 2024, at 4:30pm ETAMEX:LODEComstock Inc
25/07/202415:30Business WireBarbara Burger, Ph.D., Former Vice President, Innovation and President of Chevron Technology Ventures, Joins Bloom Energy Board of DirectorsNYSE:BEBloom Energy Corporation